Dipropanoylmorphine
A semi-synthetic opioid derived from morphine
Dipropanoylmorphine | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | 8002-20-2 |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Dipropanoylmorphine is a semi-synthetic opioid derived from morphine. It is an ester of morphine, specifically the 3,6-dipropionate ester. This compound is part of a class of drugs known as opioid analgesics, which are used for their pain-relieving properties.
Chemical Structure and Properties[edit | edit source]
Dipropanoylmorphine is chemically similar to morphine, with the addition of two propionyl groups at the 3 and 6 positions of the morphine molecule. This modification alters its pharmacokinetic properties, potentially affecting its potency, duration of action, and solubility compared to morphine.
Pharmacology[edit | edit source]
Dipropanoylmorphine acts on the opioid receptors in the central nervous system, primarily the mu-opioid receptor. This interaction leads to the inhibition of neurotransmitter release, resulting in analgesia, sedation, and euphoria. Like other opioids, it can also cause respiratory depression, constipation, and physical dependence.
Medical Use[edit | edit source]
While dipropanoylmorphine has been studied for its analgesic properties, it is not commonly used in clinical practice. The development of more effective and safer opioid analgesics has limited its use. However, it remains of interest in research settings for understanding the structure-activity relationships of opioid compounds.
Synthesis[edit | edit source]
The synthesis of dipropanoylmorphine involves the esterification of morphine with propionic anhydride. This chemical reaction results in the formation of the dipropionate ester, which is dipropanoylmorphine. The process requires careful control of reaction conditions to ensure the desired product is obtained.
Legal Status[edit | edit source]
Dipropanoylmorphine is classified as a controlled substance in many jurisdictions due to its potential for abuse and addiction. Its legal status is similar to that of other opioids, and it is subject to strict regulations regarding its manufacture, distribution, and use.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD